Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 687-706 d 880
-
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
(Cold Spring Harbor Laboratory Press, 2023-04-01) -
Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study
(American Society of Clinical Oncology, 2023-10-20) -
Reporting reimbursement price decisions for onco-hematology drugs in Spain
(Frontiers Media, 2023-10-24) -
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
(Springer Nature, 2020-09) -
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
(American Association for Cancer Research, 2023-03-01) -
Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform
(Nature Portfolio, 2022-05-18) -
Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward
(SAGE Publications, 2021-01) -
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial
(Nature Portfolio, 2024-02) -
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer
(Nature Portfolio, 2022-10) -
Robust imaging habitat computation using voxel-wise radiomics features
(Nature Research, 2021-10-11) -
Role of POLE and POLD1 in familial cancer
(Springer Nature, 2020-12) -
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis
(Nature Research, 2022-06-09)